Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Shareholder vote
confidence 98%
filed 2026-06-17
Item 5.07
This is a clear disclosure of shareholder vote results from Oak Valley Bancorp's Annual Meeting of Shareholders held June 16, 2026. Item 5.07 explicitly requires disclosure of voting results on matters submitted to security holders. The filing reports votes on two matters: (1) re-election of four board members (Christopher M. Courtney, Lynn R. Dickerson, Allison C. Lafferty, and Terrance P. Withrow), and (2) ratification of RSM US LLP as the independent auditor. Board elections and auditor ratification are material governance matters affecting investor confidence in the company's oversight and financial reporting.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-17
Item 5.07
This is a clear disclosure of shareholder voting results from the 2026 Annual Meeting held on June 11, 2026. The filing reports final vote tallies for all five proposals, including director elections, executive compensation advisory vote, stock plan approval, certificate amendment, and auditor ratification. Item 5.07 is the designated 8-K item for shareholder vote results, and the detailed voting data with percentages and broker non-votes confirms this classification.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-17
Item 5.07
SeaStar Medical held its annual meeting of shareholders on June 17, 2026, with stockholders voting on four proposals: election of Class I director John Neuman, approval of an amended 2022 Omnibus Incentive Plan increasing authorized shares from 207,046 to 896,546, ratification of WithumSmith+Brown, PC as independent auditor, and adjournment authority. All four proposals passed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-17
Item 5.07
This is a clear disclosure of shareholder vote results from Neonode's 2026 Annual Meeting of Stockholders held on June 17, 2026, covering three proposals: election of directors (Peter Lindell and Per Löfgren), ratification of Crowe LLP as independent auditor, and an advisory say-on-pay vote. The filing presents voting tallies for each proposal, which is the quintessential content of Item 5.07 shareholder_vote_results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-17
Item 5.07
This Item 5.07 filing discloses the complete results of GeoVax Labs' annual stockholder meeting held on June 17, 2026, including voting outcomes on director elections, warrant exercise proposals, auditor ratification, and executive compensation advisory votes. The disclosure of shareholder voting results on material matters such as director elections and dilutive warrant issuances (totaling over 3.8 million shares) is material to investors assessing corporate governance and capital structure changes.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-17
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Fluent, Inc.'s 2026 Annual Meeting of Stockholders held on June 17, 2026. The filing presents voting results for eight matters, including election of seven directors, say-on-pay advisory vote, auditor ratification, and approval of equity-related proposals. Shareholder vote results are material to investors as they confirm governance outcomes and approval of significant corporate actions such as equity plan amendments and warrant issuances.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-17
Item 5.07
Twilio held its Annual Meeting of stockholders on June 16, 2026, with voting results disclosed on June 17, 2026. Five proposals were voted on and approved by substantial majorities: election of four Class I directors, ratification of KPMG LLP as independent auditor, advisory vote on named executive officer compensation, and approval of amendments and restatements to the 2016 Stock Option and Incentive Plan and 2016 Employee Stock Purchase Plan.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-17
Item 5.07
This is a clear disclosure of shareholder voting results from the June 12, 2026 Annual Meeting of Stockholders, covering three proposals: election of three Class I directors (Michael Singer, Timothy Springer, and Patrick Zenner), advisory approval of named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor. The filing explicitly states the vote tallies and outcomes for each proposal, which is the core content of Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-17
Item 5.07
Groupon held its 2026 Annual Meeting of Stockholders on June 11, 2026, with shareholders voting on four proposals: election of six directors, ratification of Deloitte & Touche LLP as independent auditor, advisory approval of named executive officer compensation, and approval of a certificate amendment for officer exculpation provisions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-17
Item 5.07
This Item 5.07 disclosure reports the final voting results from Sabra Health Care REIT's annual meeting of stockholders held on June 17, 2026. The filing presents detailed voting tallies for three matters: election of seven directors, ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory approval of named executive officer compensation. Shareholder vote results are material to investors as they confirm governance composition and audit oversight for the fiscal year.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-17
The filing discloses Item 5.07 results from the Company's June 12, 2026 Annual Stockholders' Meeting, including voting outcomes on seven proposals: election of seven directors, ratification of auditor (Wipfli LLP), approval of the 2026 Equity Incentive Plan, approval of convertible note issuance authority, amendment to increase authorized shares from 100M to 750M, advisory vote on executive compensation, and advisory vote frequency. These results are material to investors as they reflect shareholder approval of significant corporate actions including equity plan adoption and substantial share authorization increases.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-17
The filing discloses results of the Company's 2026 Annual Meeting of Shareholders held on June 11, 2026, with voting outcomes on four proposals: election of four directors, ratification of the independent auditor (CBIZ CPAs P.C.), advisory approval of named executive officer compensation, and approval of an amendment to the Equity Incentive Plan increasing authorized shares by 1,750,000. Item 5.07 explicitly presents detailed voting tallies for each proposal, which is the core disclosure required for shareholder vote results under the 8-K taxonomy.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-17
The 8-K discloses results of Biofrontera's Annual Meeting of Stockholders held on June 11, 2026, under Item 5.07. The filing reports three matters voted on: election of two Class II directors (Beth J. Hoffman, Ph.D. and Kevin D. Weber), approval of an amendment to the 2021 Omnibus Incentive Plan increasing authorized shares from 3.75M to 8.75M, and ratification of CBIZ CPAs P.C. as independent auditor. These are routine but material shareholder votes affecting governance and equity authorization.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-17
The filing discloses Item 5.07 results from Hepion Pharmaceuticals' 2026 Annual Meeting of Stockholders held on June 17, 2026, including voting outcomes on three proposals: election of five directors (Gary Stetz, Vincent LoPriore, Michael Purcell, Sireesh Appajosyula, and Chase LoPriore), ratification of Grassi & Co. as independent auditors, and approval of an amendment to the 2023 Omnibus Equity Incentive Plan to increase authorized shares to 8,000,000. These shareholder votes are material to investors as they determine board composition and equity plan capacity.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-17
Item 5.07
AMC Global Media held its annual meeting of stockholders on June 16, 2026, with voting results disclosed on four proposals: election of Class A and Class B directors, ratification of KPMG LLP as independent auditor, advisory approval of named executive officer compensation, and approval of the Amended and Restated 2011 Stock Plan for Non-Employee Directors.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-17
Item 5.07
Playboy held its 2026 Annual Meeting of Stockholders on June 16, 2026, with shareholders voting on five proposals: election of two Class III directors (Tracey Edmonds and James Yaffe), approval of an amendment to the 2021 Equity and Incentive Compensation Plan increasing available shares by 10 million, ratification of RSM US LLP as independent auditors, a non-binding Say on Pay vote, and approval of an adjournment proposal. All proposals passed with detailed vote tallies disclosed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-17
Item 5.07
This is a clear disclosure of shareholder vote results from Energy Focus's annual meeting held June 12, 2026, reporting the election of seven directors and ratification of GBQ Partners LLC as independent auditor. Item 5.07 explicitly requires disclosure of voting results at stockholder meetings, and the filing presents certified vote tallies for both proposals with detailed breakdowns of votes for, against, and withheld/abstained.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-17
Item 5.07
This Item 5.07 disclosure reports the results of Forward Air Corporation's annual stockholder meeting held on June 17, 2026, including voting outcomes on four proposals: election of five directors, advisory vote on named executive officer compensation, ratification of KPMG LLP as independent auditor, and approval of an amendment to the 2025 Omnibus Incentive Compensation Plan. The filing presents vote tallies (For, Against, Abstentions, Broker Non-Votes) for each proposal, which is the standard format for shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-17
Item 5.07
This 8-K Item 5.07 discloses the certified results of Roku's June 11, 2026 annual meeting of stockholders, including voting outcomes on three proposals: election of Class III directors (Jeffrey Hastings, Neil Hunt, Anthony Wood), advisory approval of named executive officer compensation, and ratification of Deloitte & Touche LLP as independent auditor. The filing presents vote tallies with percentages in favor for each matter, which is the core disclosure required under Item 5.07 for shareholder meeting results.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-17
Item 5.07
This Item 5.07 filing discloses the complete voting results from Zai Lab's 2026 Annual General Meeting of Shareholders held on June 17, 2026. The section presents detailed vote tallies for 14 proposals, including director re-elections (Proposals 1–9), auditor appointment (Proposal 10), auditor compensation authorization (Proposal 11), advisory vote on named executive officer compensation (Proposal 12), and general mandates for share issuance and repurchase (Proposals 13–14). All proposals were carried as ordinary resolutions. This is a textbook shareholder_vote_results disclosure required under Item 5.07 of Form 8-K.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-17
Item 5.07
This is a clear disclosure of shareholder vote results from Century Aluminum's 2026 Annual Meeting held on June 15, 2026. The filing reports voting outcomes for three proposals: election of seven directors, ratification of Deloitte & Touche LLP as independent auditor, and an advisory vote on named executive officer compensation. All three proposals passed with substantial majorities, and the detailed vote tallies (for, against, withheld, abstain, broker non-votes) are characteristic of Item 5.07 shareholder vote disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-17
Item 5.07
Virco held its 2026 Annual Meeting of Shareholders on June 16, 2026, with voting results on three matters: election of directors Craig L. Levra and Robert R. Lind, advisory approval of named executive officer compensation, and ratification of Baker Tilly US, LLP as independent auditor. All three proposals passed with substantial majorities.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-17
Item 5.07
This is a clear disclosure of shareholder vote results from DXP Enterprises' June 12, 2026 Annual Shareholders Meeting, covering three proposals: election of six directors, advisory vote on named executive officer compensation, and ratification of PricewaterhouseCoopers as independent auditor. The filing presents certified vote tabulations for each proposal with detailed vote counts and percentages, which is the hallmark of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-17
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of LendingTree's 2026 Annual Meeting of Stockholders held on June 17, 2026. The filing presents voting tallies for three proposals: election of nine directors, advisory approval of executive compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor. All three proposals passed with substantial majorities, and the disclosure includes vote counts (For, Against, Abstain, Broker Non-Votes) for each matter, which is the standard format for shareholder vote results.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-17
Item 5.07
This is a clear disclosure of shareholder voting results from BayCom Corp's 2026 Annual Meeting of Shareholders held on June 16, 2026. The filing reports final voting tallies for three proposals: election of nine directors, advisory vote on executive compensation, and ratification of Baker Tilly US, LLP as independent auditor. All three proposals passed with substantial majorities, making this a routine but material shareholder governance disclosure under Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-17
Item 5.07
Stockholders approved multiple material matters at the Annual Meeting of Stockholders, including election of two Class I directors (Charles M. Sledge and Katherine E. Wanner), ratification of Ernst & Young LLP as auditor, and significant Charter amendments including removal of staggered board, adoption of majority voting for directors, a 1-for-50 reverse stock split, removal of Class B common stock references, and approval of a potential dilutive issuance exceeding 20% of outstanding shares in connection with a Restructuring Transaction.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-17
Item 5.07
This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting of Stockholders held on June 16, 2026. The filing presents voting outcomes for three proposals: election of five directors, ratification of BDO USA as independent auditors, and advisory approval of executive compensation. These are routine but material governance matters that affect investor understanding of board composition and corporate oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 92%
filed 2026-06-17
Item 5.07
Flag Ship Acquisition Corp held an Extraordinary General Meeting on June 11, 2026, where shareholders voted to extend the business combination deadline from June 20, 2026 to June 20, 2027, with the Extension Proposal receiving 2,993,175 votes in favor and 1,267,577 against, achieving the required two-thirds majority. The vote resulted in 1,507,257 ordinary shares being redeemed by shareholders exercising redemption rights, materially affecting the company's capital structure and Trust Account balance.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-17
Item 5.07
This is a clear Item 5.07 disclosure of shareholder vote results from AEON Biopharma's Annual Meeting of Stockholders held on June 17, 2026. The filing reports the final certified voting results for two proposals: (1) election of Class III directors Marc Forth and Seongsoo Park for three-year terms, and (2) ratification of KPMG LLP as independent auditor. Director elections and auditor ratifications are material governance matters affecting investor confidence in board composition and financial oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-17
Item 5.07
Shareholders holding 77.45% of outstanding Class B Common Stock consented on June 17, 2026 to the adoption of an Amended and Restated Certificate of Incorporation that materially modifies the automatic conversion mechanics of Class B common stock by adding new Permitted Transferee categories (Qualifying Purpose Trusts and Qualifying Estate Planning Trusts) and exempting such trusts from automatic conversion upon death or permanent incapacity.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-17
Item 5.07
This is a clear disclosure of shareholder voting results from MNTN's June 11, 2026 annual meeting of stockholders. The filing reports the election of three Class I directors (Joseph Kaiser, Tony Weisman, and Pali Bhat) and ratification of KPMG LLP as independent auditor, with detailed vote tallies for each proposal. This is a routine but material Item 5.07 disclosure required by SEC rules for annual meeting outcomes.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-17
Item 5.07
This 8-K Item 5.07 discloses the results of Amprius Technologies' June 11, 2026 annual meeting of stockholders, including voting outcomes for two proposals: election of directors Kathleen Bayless and Thomas M. Stepien, and ratification of Deloitte & Touche LLP as independent auditor. The filing presents vote tallies (For, Against/Withheld, Abstentions, Broker Non-Votes) and confirms both proposals passed, which is the core disclosure required under Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-16
Item 5.07
This Item 5.07 discloses the results of the 2026 Annual Meeting of Stockholders, including voting outcomes on three proposals: election of three directors (Mark A. Frantz, Carol J. Lindstrom, and Arshad Matin), advisory approval of executive compensation, and ratification of Deloitte & Touche LLP as independent auditor. The filing presents vote tallies (For, Against, Abstain, Broker Non-Votes) for each proposal, which is the core disclosure required under Item 5.07 for shareholder meeting results.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
Urban One held its 2026 Annual Meeting of Stockholders on June 11, 2026, with voting results on the election of six directors (Terry L. Jones, Brian W. McNeill, Catherine L. Hughes, Alfred C. Liggins III, B. Doyle Mitchell Jr., and D. Geoffrey Armstrong), approval of the 2026 Equity and Performance Incentive Plan, and ratification of PricewaterhouseCoopers LLP as independent auditor.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
Columbia Sportswear held its Annual Meeting of shareholders with 49.6 million shares (97% of outstanding) voted. Results included election of all 10 directors with strong majorities, ratification of Deloitte & Touche LLP as auditor, approval of executive compensation, approval of the Amended and Restated 2020 Stock Incentive Plan (increasing authorized equity from 4.5 million to 9 million shares), and rejection of a proxy access proposal.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Chipotle's 2026 annual meeting of shareholders held on June 11, 2026. The filing presents final voting tallies for three proposals: election of ten directors (all elected with strong majorities), advisory approval of executive compensation, and ratification of Ernst & Young LLP as independent auditor. These are material governance events that affect investor understanding of board composition and shareholder sentiment on compensation and audit oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
This Item 5.07 filing discloses the results of the June 12, 2026 annual meeting of shareholders, including voting outcomes on four proposals: election of three directors, advisory approval of executive compensation, frequency of future compensation votes, and amendment to the Articles of Incorporation regarding board size. The disclosure of shareholder vote results at an annual meeting is the textbook definition of Item 5.07 and the shareholder_vote_results event type.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
Palvella Therapeutics held its Annual Meeting on June 16, 2026, with stockholders voting on six proposals: election of three Class III directors (Jenkins, Davis, Doux), ratification of Ernst & Young LLP as independent auditor, advisory approval of named executive officer compensation, advisory frequency vote on compensation (approved annually), approval of an amendment to the 2024 Equity Incentive Plan increasing authorized shares by 750,000, and adjournment authority. All proposals passed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
This is a clear disclosure of shareholder voting results from Latch's June 10, 2026 annual meeting of stockholders, filed under Item 5.07. The filing presents tabulated voting outcomes for three proposals: election of six directors, ratification of BDO USA as independent auditor, and advisory approval of named executive officer compensation. All three proposals passed with substantial majorities, making this a routine but material shareholder governance disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
This is a clear Item 5.07 disclosure of shareholder voting results from ExlService's 2026 Annual Meeting of Stockholders. The filing reports the final vote tallies for three proposals: election of seven board directors (all elected), ratification of Deloitte & Touche LLP as auditor (approved), and Say-on-Pay advisory vote (approved). The detailed voting results with For/Against/Abstain/Broker Non-Vote counts are the core content of the filing.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-06-16
The 6-K discloses the results of Ardmore Shipping's 2026 Annual Meeting of Shareholders held on June 15, 2026, reporting the election of three Class I Directors (Mats Berglund, Kirsi Tikka, and Gernot Ruppelt) with specific vote tallies for and withheld. This is a direct disclosure of shareholder vote results under Item 5.07 equivalent, which is material to investors as it reflects the composition of the board of directors.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
This is a clear disclosure of shareholder voting results from John Marshall Bancorp's Annual Meeting of Shareholders held on June 16, 2026. The filing reports the outcomes of two proposals: (1) election of eight directors with detailed vote tallies for each nominee, and (2) ratification of Yount, Hyde & Barbour, P.C. as the independent auditor. This is a quintessential Item 5.07 disclosure and is material to investors as it confirms the composition of the board and auditor appointment.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
Norwegian Cruise Line Holdings held its annual general meeting on June 11, 2026, with shareholders voting on six proposals including election of three Class I directors, advisory approval of executive compensation, auditor ratification, and approval of a board declassification proposal.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
This Item 5.07 disclosure reports the results of the Annual Meeting of Shareholders held on June 11, 2026, including: (1) election of seven board members with vote tallies for each director; (2) non-binding advisory approval of named executive officer compensation (28,547,283 shares for); (3) shareholder approval of annual frequency for future say-on-pay votes; and (4) ratification of Ernst & Young LLP as independent auditor (29,842,514 shares for). These are standard shareholder vote results that materially inform investors about board composition and governance decisions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
This Item 5.07 filing discloses the results of Battalion Oil Corporation's June 11, 2026 Annual Meeting of Stockholders, including voting outcomes for two proposals: election of four directors (Jonathan D. Barrett, Gregory S. Hinds, William D. Rogers, and Matthew B. Steele) and ratification of Deloitte & Touche LLP as independent auditor. The tabulated vote counts for each proposal are the core disclosure, making this a classic shareholder_vote_results event.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
Elutia Inc. held its annual meeting of stockholders on June 11, 2026, at which shareholders voted on five proposals: election of two Class III directors (David Colpman and Kevin Rakin), ratification of PricewaterhouseCoopers LLP as auditor, approval of the First Amendment to the 2020 Incentive Award Plan, advisory approval of named executive officer compensation, and advisory vote on say-on-pay frequency. All five proposals passed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
This 8-K Item 5.07 discloses the final results of Adagio Medical's 2026 Annual Meeting of Stockholders held on June 16, 2026, including voting outcomes for two proposals: election of two directors (Orly Mishan and Sean Salmon, both elected) and ratification of WithumSmith+Brown, PC as independent auditor (ratified with overwhelming support). The disclosure provides vote counts, shares outstanding, and quorum information, which is the standard format for shareholder vote results required under Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
This Item 5.07 disclosure reports the final voting results from Gyre Therapeutics' June 10, 2026 Annual Meeting of Stockholders, including election of directors (David M. Epstein and Dan Weng), non-binding advisory vote on executive compensation, ratification of Grant Thornton Zhitong as independent auditor, and approval of Series B Preferred Stock conversion. The filing presents tabulated vote counts for each proposal, which is the core content of a shareholder_vote_results event.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
VirnetX held its 2026 Annual Meeting of Stockholders with shareholder votes on multiple proposals: election of Class I directors (Kendall Larsen and Gary W. Feiner), ratification of auditor Farber Hass Hurley LLP, advisory approval of named executive officer compensation, and approval of an amendment to the 2013 Equity Incentive Plan increasing the share reserve by 1,000,000 shares. Vote tallies for each proposal are disclosed with results for votes for, against, withheld, abstentions, and broker non-votes.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
This Item 5.07 disclosure reports the results of Thryv Holdings' annual stockholder meeting held on June 11, 2026, including the election of two Class III directors (John Slater and Joseph A. Walsh), ratification of Grant Thornton LLP as independent auditor, and an advisory vote on named executive officer compensation. The detailed vote tallies for each proposal are the core content of the filing, which is the standard format for shareholder vote results disclosures.
View raw filing on EDGAR →